vTv Therapeutics
VTVT
VTVT
20 hedge funds and large institutions have $1.28M invested in vTv Therapeutics in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
63% less capital invested
Capital invested by funds: $3.4M → $1.28M (-$2.13M)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$451K | |
| 2 | +$58.1K | |
| 3 | +$42K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$38K |
| 5 |
BlackRock
New York
|
+$19K |
Top Sellers
| 1 | -$2.1M | |
| 2 | -$382K | |
| 3 | -$38.6K | |
| 4 |
Barclays
London,
United Kingdom
|
-$35.2K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$30K |